Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CSWYF

China Shineway Pharmaceutical Group Limited

USD

Set alert

Price alert · CSWYF

All alert types
1.00 USD 0.00 0.00%
As of Oct 29, 2026
0.9253 Day range 0.9253
1.00 52-week range 1.00
YTD
+0.40%
1 year
+0.40%
Open
0.9253
Prev close
1.00
Mkt cap
758.42M
Vol
100
Avg vol
0
EPS
0.20
P/E
5.02
More statistics
Low
0.9253
High
0.9253

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CSWYF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

4.19 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E 5.5×
FY 2016: 11.3×FY 2017: 15.2×FY 2018: 13.3×FY 2019: 13.3×FY 2020: 21.9×FY 2021: 8.1×FY 2022: 6.8×FY 2023: 5.1×FY 2024: 6.6×FY 2025: 5.5×
FY 2016 5y median 6.6× FY 2025
P/S 1.7×
FY 2016: 3.4×FY 2017: 3.6×FY 2018: 2.6×FY 2019: 2.5×FY 2020: 2.4×FY 2021: 1.4×FY 2022: 1.2×FY 2023: 0.2×FY 2024: 1.5×FY 2025: 1.7×
FY 2016 5y median 1.4× FY 2025
P/B 0.7×
FY 2016: 1.3×FY 2017: 1.1×FY 2018: 1.2×FY 2019: 1.2×FY 2020: 1.1×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.7×
FY 2016 5y median 0.7× FY 2025
P/FCF 5.4×
FY 2016: 9.4×FY 2017: 12.3×FY 2018: 14.0×FY 2019: 18.9×FY 2020: 10.1×FY 2021: 6.7×FY 2022: 4.5×FY 2023: 5.8×FY 2024: 6.7×FY 2025: 5.4×
FY 2016 5y median 5.8× FY 2025
EV/EBITDA -1.2×
FY 2016: 5.0×FY 2017: 6.9×FY 2018: 4.5×FY 2019: 6.1×FY 2020: 5.2×FY 2021: 0.4×FY 2022: -0.0×FY 2023: -3.9×FY 2024: -0.2×FY 2025: -1.2×
FY 2016 5y median -0.2× FY 2025
EV/Sales -0.5×
FY 2016: 1.8×FY 2017: 1.6×FY 2018: 1.2×FY 2019: 1.2×FY 2020: 0.9×FY 2021: 0.1×FY 2022: -0.0×FY 2023: -1.1×FY 2024: -0.1×FY 2025: -0.5×
FY 2016 5y median -0.1× FY 2025
FCF Yield 18.4%
FY 2016: 10.7%FY 2017: 8.1%FY 2018: 7.2%FY 2019: 5.3%FY 2020: 9.9%FY 2021: 14.9%FY 2022: 22.1%FY 2023: 17.2%FY 2024: 14.9%FY 2025: 18.4%
FY 2016 5y median 17.2% FY 2025

Profitability

Gross Margin 72.3%
FY 2016: 64.5%FY 2017: 66.0%FY 2018: 73.0%FY 2019: 73.2%FY 2020: 74.9%FY 2021: 74.8%FY 2022: 74.4%FY 2023: 75.1%FY 2024: 75.0%FY 2025: 72.3%
FY 2016 5y median 74.8% FY 2025
Operating Margin 22.9%
FY 2016: 28.3%FY 2017: 21.3%FY 2018: 19.3%FY 2019: 17.5%FY 2020: 15.9%FY 2021: 16.6%FY 2022: 18.1%FY 2023: 21.6%FY 2024: 22.3%FY 2025: 22.9%
FY 2016 5y median 21.6% FY 2025
Net Margin 30.3%
FY 2016: 29.6%FY 2017: 23.5%FY 2018: 19.7%FY 2019: 18.6%FY 2020: 11.1%FY 2021: 17.6%FY 2022: 18.3%FY 2023: 3.0%FY 2024: 22.2%FY 2025: 30.3%
FY 2016 5y median 18.3% FY 2025
ROE 11.8%
FY 2016: 11.0%FY 2017: 7.5%FY 2018: 9.1%FY 2019: 8.8%FY 2020: 4.8%FY 2021: 9.4%FY 2022: 11.7%FY 2023: 13.8%FY 2024: 11.3%FY 2025: 11.8%
FY 2016 5y median 11.7% FY 2025
ROIC 6.2%
FY 2016: 8.7%FY 2017: 5.1%FY 2018: 6.5%FY 2019: 5.9%FY 2020: 4.0%FY 2021: 6.7%FY 2022: 8.7%FY 2023: 10.2%FY 2024: 7.8%FY 2025: 6.2%
FY 2016 5y median 7.8% FY 2025
ROA 8.8%
FY 2016: 9.5%FY 2017: 6.5%FY 2018: 7.8%FY 2019: 7.2%FY 2020: 3.9%FY 2021: 7.7%FY 2022: 9.1%FY 2023: 10.2%FY 2024: 8.4%FY 2025: 8.8%
FY 2016 5y median 8.8% FY 2025

Growth (YoY)

Revenue -17.0%
FY 2016: -1.6%FY 2017: -10.6%FY 2018: 43.3%FY 2019: 1.5%FY 2020: -7.5%FY 2021: 26.3%FY 2022: 27.1%FY 2023: 694.0%FY 2024: -88.2%FY 2025: -17.0%
FY 2016 FY 2025
Operating Income -14.8%
FY 2016: -6.7%FY 2017: -32.9%FY 2018: 29.9%FY 2019: -8.2%FY 2020: -15.7%FY 2021: 31.6%FY 2022: 38.4%FY 2023: 849.5%FY 2024: -87.8%FY 2025: -14.8%
FY 2016 FY 2025
EPS (diluted) 13.5%
FY 2016: -9.5%FY 2017: -30.3%FY 2018: 20.8%FY 2019: 1.6%FY 2020: -43.1%FY 2021: 100.0%FY 2022: 29.7%FY 2023: 33.3%FY 2024: -13.3%FY 2025: 13.5%
FY 2016 FY 2025
Free Cash Flow 18.4%
FY 2016: 10.3%FY 2017: -28.9%FY 2018: -7.9%FY 2019: -28.4%FY 2020: 69.7%FY 2021: 11.2%FY 2022: 62.2%FY 2023: -22.0%FY 2024: -3.3%FY 2025: 18.4%
FY 2016 FY 2025

Financial Health

Current Ratio 3.7×
FY 2016: 6.3×FY 2017: 6.4×FY 2018: 6.0×FY 2019: 4.4×FY 2020: 30.1×FY 2021: 5.2×FY 2022: 4.1×FY 2023: 3.4×FY 2024: 3.5×FY 2025: 3.7×
FY 2016 5y median 3.7× FY 2025
Quick Ratio 3.4×
FY 2016: 5.9×FY 2017: 6.0×FY 2018: 5.4×FY 2019: 4.1×FY 2020: 27.7×FY 2021: 5.1×FY 2022: 3.7×FY 2023: 3.0×FY 2024: 3.2×FY 2025: 3.4×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -5.1×
FY 2016: -4.2×FY 2017: -8.2×FY 2018: -4.9×FY 2019: -6.6×FY 2020: -8.8×FY 2021: -5.4×FY 2022: -5.0×FY 2023: -4.5×FY 2024: -4.7×FY 2025: -5.1×
FY 2016 5y median -5.0× FY 2025
Interest Coverage 126×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 178×FY 2020: 25.4×FY 2021: 419×FY 2022: 1133×FY 2023: 356×FY 2024: 137×FY 2025: 126×
FY 2016 5y median 356× FY 2025

Dividends

Dividend Yield 6.7%
FY 2016: 3.9%FY 2017: 3.9%FY 2018: 3.9%FY 2019: 3.7%FY 2020: 3.9%FY 2021: 10.1%FY 2022: 4.9%FY 2023: 6.4%FY 2024: 7.4%FY 2025: 6.7%
FY 2016 5y median 6.7% FY 2025
Payout Ratio 37.4%
FY 2016: 44.9%FY 2017: 58.6%FY 2018: 51.6%FY 2019: 48.9%FY 2020: 86.5%FY 2021: 81.5%FY 2022: 32.6%FY 2023: 32.6%FY 2024: 48.6%FY 2025: 37.4%
FY 2016 5y median 37.4% FY 2025

Annual · latest fiscal year ends 2025-12-31